Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

AVTX

Avalo Therapeutics, Inc.

CIK 0001534120 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$19.95
↑ 0.74 (3.85%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$1.05B
P/E Ratio
-12.38
EPS
-5.84
Dividend Yield
Not covered
52W Position
78%
Beta
1.48

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
15.35
P/S
Not covered
EV/Revenue
Not covered
ROE
-124.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 78%
$4.61$24.27

Latest Financials

2025-12-31 FY
Revenue
$59.00K
Net Income
-$78.26M
Total Assets
$116.46M
Free Cash Flow
–

Recent news